Approval · Notice of Compliance 34256 · 2024
EUGIA-HYDROXYUREA: Notice of Compliance 34256
Issued October 22, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34256
- Date
- October 22, 2024
- Company
- Eugia Pharma Inc.Woodbridge, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- HYDREA (Bristol-Myers Squibb Canada)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EUGIA-HYDROXYUREA | 02552582 | Approved |
Medicinal ingredients
- HYDROXYUREA 500 MG per CAP